Terms: = Leukemia AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
351 results:
1. The establishment of a multiple myeloma clinical registry in the Asia-Pacific region: The Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR).
Aoki N; Chen PY; Chen W; Chng WJ; Gan GG; Goh YT; Hou J; Huang J; Kim K; Lee JJ; Lu J; McQuilten ZK; Min CK; Moore E; Oliver L; Waters NA; Wellard C; Wood EM; Yeh SP; Spencer A;
BMC Med Res Methodol; 2024 May; 24(1):102. PubMed ID: 38698331
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
Guan J; Ma J; Chen B
Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
[TBL] [Abstract] [Full Text] [Related]
3. Predictors of Post-traumatic Stress Symptoms (PTSS), Depression, and Anxiety among Caregivers of Children with Acute Lymphoblastic Leukaemia (ALL).
Chong ASS; Ahmad M; Mohd Harizan NB; Alias H; Iqbal Hussain R; Lateh A; Chan CMH
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1923-1929. PubMed ID: 37378920
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical Characteristics and Survival Analysis of Patients with Plasma Cell leukemia].
Wang SF; Qin XQ; Guo QH; Wang JY; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):693-698. PubMed ID: 37356928
[TBL] [Abstract] [Full Text] [Related]
5. flt4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia.
Lee JY; Lee SE; Han AR; Lee J; Yoon YS; Kim HJ
Haematologica; 2023 Nov; 108(11):2933-2945. PubMed ID: 37317880
[TBL] [Abstract] [Full Text] [Related]
6. Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma.
Kaiser MF; Hall A; Walker K; Sherborne A; De Tute RM; Newnham N; Roberts S; Ingleson E; Bowles K; Garg M; Lokare A; Messiou C; Houlston RS; Jackson G; Cook G; Pratt G; Owen RG; Drayson MT; Brown SR; Jenner MW
J Clin Oncol; 2023 Aug; 41(23):3945-3955. PubMed ID: 37315268
[TBL] [Abstract] [Full Text] [Related]
7. Identification of signature genes and drug candidates for primary plasma cell leukemia: An integrated system biology approach.
Chaudhary RK; Patil P; Ananthesh L; Gowdru Srinivasa M; Mateti UV; Shetty V; Khanal P
Comput Biol Med; 2023 Aug; 162():107090. PubMed ID: 37295388
[TBL] [Abstract] [Full Text] [Related]
8. Plasma Cell leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation.
Tang ASO; Ahmad Asnawi AW; Koh AZY; Chong SL; Liew PK; Selvaratnam V; Md Fauzi A; Lau NS; Tan SM
Am J Case Rep; 2023 Mar; 24():e938868. PubMed ID: 36882990
[TBL] [Abstract] [Full Text] [Related]
9. Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Single-Center Retrospective Analysis.
Shank BR; Primeaux B; Yeung EK; Horowitz SB; Lee IY; Roccograndi L; Feng L; Kaufman GP; Lee HC; Manasanch EE; Patel KK; Orlowski RZ; Weber DM; Becnel MR; Thomas SK
Clin Lymphoma Myeloma Leuk; 2023 Apr; 23(4):279-290. PubMed ID: 36797154
[TBL] [Abstract] [Full Text] [Related]
10. Therapeutic potential of flt4-targeting peptide in acute myeloid leukemia.
Lee JY; Park S; Han AR; Hwang HS; Kim HJ
Cancer Immunol Immunother; 2023 Sep; 72(9):2919-2925. PubMed ID: 36763100
[TBL] [Abstract] [Full Text] [Related]
11. Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party.
Jung SH; Kim K; Yoon SE; Moon JH; Kim D; Kim HJ; Kim MK; Kim KH; Lee HJ; Lee JH; Kim SH; Yoo KH; Lee JH; Lee JJ
Blood Cancer J; 2022 Nov; 12(11):157. PubMed ID: 36404323
[TBL] [Abstract] [Full Text] [Related]
12. [PAX5-positive plasma cell leukemia presenting as lymphocytosis].
Tateno S; Hirao M; Kikuchi T; Tsukada Y; Kunieda H; Osada M; Yamazaki K; Denda R; Hirose S; Matsushita M; Ichikawa D; Hattori Y
Rinsho Ketsueki; 2022; 63(10):1415-1420. PubMed ID: 36351649
[TBL] [Abstract] [Full Text] [Related]
13. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell leukemia-Like Multiple Myeloma.
Jelinek T; Bezdekova R; Zihala D; Sevcikova T; Anilkumar Sithara A; Pospisilova L; Sevcikova S; Polackova P; Stork M; Knechtova Z; Venglar O; Kapustova V; Popkova T; Muronova L; Chyra Z; Hrdinka M; Simicek M; Garcés JJ; Puig N; Cedena MT; Jurczyszyn A; Castillo JJ; Penka M; Radocha J; Mateos MV; San-Miguel JF; Paiva B; Pour L; Rihova L; Hajek R
J Clin Oncol; 2023 Mar; 41(7):1383-1392. PubMed ID: 36315921
[TBL] [Abstract] [Full Text] [Related]
14. Identification of High-Risk Multiple Myeloma With a Plasma Cell leukemia-Like Transcriptomic Profile.
Hofste Op Bruinink D; Kuiper R; van Duin M; Cupedo T; van der Velden VHJ; Hoogenboezem R; van der Holt B; Beverloo HB; Valent ET; Vermeulen M; Gay F; Broijl A; Avet-Loiseau H; Munshi NC; Musto P; Moreau P; Zweegman S; van de Donk NWCJ; Sonneveld P
J Clin Oncol; 2022 Sep; 40(27):3132-3150. PubMed ID: 35357885
[TBL] [Abstract] [Full Text] [Related]
15. Plasma cell leukemia: Retrospective review of cases at Monter Cancer Center/Northwell Health Cancer Institute, 2014-2019.
Cotte C; Hartley-Brown M
Curr Probl Cancer; 2022 Jun; 46(3):100831. PubMed ID: 35091270
[TBL] [Abstract] [Full Text] [Related]
16. Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report.
Vo K; Guan T; Banerjee R; Lo M; Young R; Shah N
J Oncol Pharm Pract; 2022 Jul; 28(5):1244-1248. PubMed ID: 35084252
[TBL] [Abstract] [Full Text] [Related]
17. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Blood Cancer J; 2021 Dec; 11(12):192. PubMed ID: 34857730
[TBL] [Abstract] [Full Text] [Related]
18. Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma.
Lee Y; Yun J; Jeong D; Ryu S; Kwon SR; Yun H; Kim SM; Park JH; Lee DS
Leuk Lymphoma; 2022 Feb; 63(2):385-394. PubMed ID: 34592901
[TBL] [Abstract] [Full Text] [Related]
19. Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia.
Bezdekova R; Jelinek T; Kralova R; Stork M; Polackova P; Vsianska P; Brozova L; Jarkovsky J; Almasi M; Boichuk I; Knechtova Z; Penka M; Pour L; Sevcikova S; Hajek R; Rihova L
Br J Haematol; 2021 Oct; 195(1):95-107. PubMed ID: 34500493
[TBL] [Abstract] [Full Text] [Related]
20. A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia.
Vachhani P; Baron J; Freyer CW; Miller A; Wetzler M; Thompson JE; Griffiths EA; Wang ES
Leuk Res; 2021 Aug; 107():106588. PubMed ID: 33957371
[TBL] [Abstract] [Full Text] [Related]
[Next]
